1504 related articles for article (PubMed ID: 28893626)
1. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.
Yang J; Gong Y; Sontag DP; Corbin I; Minuk GY
Mol Biol Rep; 2018 Oct; 45(5):1023-1036. PubMed ID: 30069818
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.
Wen X; Reynolds L; Mulik RS; Kim SY; Van Treuren T; Nguyen LH; Zhu H; Corbin IR
Gastroenterology; 2016 Feb; 150(2):488-98. PubMed ID: 26484708
[TBL] [Abstract][Full Text] [Related]
4. Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.
Moss LR; Mulik RS; Van Treuren T; Kim SY; Corbin IR
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2363-2376. PubMed ID: 27418237
[TBL] [Abstract][Full Text] [Related]
5. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
6. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.
Li J; Canseco D; Wang Y; Vale G; Chaudhary J; Anwar A; Baniasadi H; Williams NS; Gopal P; Sutphin PD; McDonald JG; Putnam WC; Corbin IR
Eur J Pharm Biopharm; 2021 Jan; 158():273-283. PubMed ID: 33242579
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.
Reynolds L; Mulik RS; Wen X; Dilip A; Corbin IR
Nanomedicine (Lond); 2014 Jul; 9(14):2123-41. PubMed ID: 24397600
[TBL] [Abstract][Full Text] [Related]
8. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
9. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.
Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W
Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528
[TBL] [Abstract][Full Text] [Related]
10. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
[TBL] [Abstract][Full Text] [Related]
11. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
Ji J; Cheng Z; Zhang J; Wu J; Xu X; Guo C; Feng J
J Cell Mol Med; 2024 Apr; 28(8):e18335. PubMed ID: 38652216
[TBL] [Abstract][Full Text] [Related]
13. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
Lim K; Han C; Dai Y; Shen M; Wu T
Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
[TBL] [Abstract][Full Text] [Related]
15. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.
Mulik RS; Zheng H; Pichumani K; Ratnakar J; Jiang QX; Corbin IR
Chem Phys Lipids; 2017 Apr; 204():65-75. PubMed ID: 28342772
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
18. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
Rohr-Udilova N; Sieghart W; Eferl R; Stoiber D; Björkhem-Bergman L; Eriksson LC; Stolze K; Hayden H; Keppler B; Sagmeister S; Grasl-Kraupp B; Schulte-Hermann R; Peck-Radosavljevic M
Hepatology; 2012 Apr; 55(4):1112-21. PubMed ID: 22105228
[TBL] [Abstract][Full Text] [Related]
20. Repeated trans-arterial treatments of LDL-DHA nanoparticles induce multiple pathways of tumor cell death in hepatocellular carcinoma bearing rats.
Wang Y; Li J; do Vale GD; Chaudhary J; Anwar A; McDonald JG; Qin T; Zhang H; Corbin IR
Front Oncol; 2022; 12():1052221. PubMed ID: 36505796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
